Thank you for subscribing.

Please check your email to confirm.

Unsubscribe success..

You already subscribed and confirmed.

Please check your email.

You already subscribed.

Please check your email to confirm.

Yaoyanshe Announced its Series C Round of Funding of CNY 300 Million
Yaoyanshe Announced its Series C Round of Funding of CNY 300 Million
Image Credit: Pexels
Associated Company
EqualOcean EqualOcean

Yaoyanshe(药研社) recently announced its Series C round of funding of CNY 300 million (USD 42.62 million). Eastern Bell Capital (钟鼎资本) and Sequoia China(红杉中国) led the investment, followed by Matrix Partners China (经纬中国), Vision Plus Capital (元璟资本) and Genesis Capital (元生资本). 

This round of financing is used for developing technology product, building a supply chain, improving client experience and constructing a talent platform.   

Yaoyanshe provides new types of CRO (contract research organization) and CMO (contract manufacturing organization) services, ranging from drug development through drug manufacturing in the pharmaceutical industry outsourced on a contract basis. 

As an internet platform, Yaoyanshe emphasizes the importance of data and talents. This April, Yaoyanshe launched a clinic research entrance platform Trial.Link that connects drug enterprises, hospitals, researchers, industry practitioners and patients. 

Leveraging data technology, it helps pharmaceutical enterprises to achieve high efficiency and standardization with lower cost during clinical experiments. So far, it has attracted more than 180 hospitals and 300 drug manufacturers to its platform. It is reported that the platform has shortened the development period by 20% and lowered development cost by 15%.

Drug development is a cash-burning, time-consuming process involving multiparty cooperation. Thanks to policy encouragement, a host of drug development start-ups have flourished. Smaller drug developers are especially reliant on CRO services. 

Xiong Fei, Partner at Matrix Partners China, has said that medical research outsourcing is worth CNY 50 billion with an annual growth rate of around 20%. 

Enterprise Information

EqualOcean is a leading industry tech media and an investment research company.
CATEGORIES: AI, Research
Last Funding Type
Series C
Number of Employees
200
Number of Funding Rounds
6
Total Funding Amount
26.79M

Enterprise Information

EqualOcean
EqualOcean is a leading industry tech media and an investment research company.
CATEGORIES: AI, Research
Last Funding Type
Series C
Number of Employees
200
Number of Funding Rounds
6
Total Funding Amount
26.79M

Reach the Author!

Ask the author questions about the copied text

MOST READ

THE LATEST

Any Question

EqualOcean is a leading industrial tech media and investment research company that focuses on technological and industrial innovation in China.

We aim to assist Chinese entrepreneurial enterprises to break into the global market and provide overseas investors, VCs, and enterprises with a deeper understanding of China's business environment and to seize opportunities in China.

Join over 800,000 of your peers